Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Oncology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Stomach Cancer Clinical Trials

A listing of Stomach Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (9) clinical trials

A clinical research study of S-1 de-escalation, Chemotherapy by Investigator's choice for the treatment of Esophageal Adenocarcinoma, Gastric Cancer, Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastroesophageal Junction Adenocarcinoma, Esophageal Cancer, Gastric Adenocarcinoma

Open-label, multi-center, controlled, randomized, parallel-group phase II trial in patients with metastatic esophagogastric cancer having received induction chemotherapy. Patients will be registered before or after application of a three-months induction chemotherapy . This 12-week induction therapy will consist of one of the following regimens: FLO/mod. Folfox-6, Cisplatin/5-FU, Cisplatin/S-1, FLOT, EOX/EOF ...


Patients are needed to participate in a clinical research study of S-1, Cisplatin, Oxaliplatin

The primary endpoint is Overall survival time (OS).Secondary is overall response rate (ORR), time to treatment failure (TTF),treatment to progression time (TTP)and the adverse reactions of the two groups (AE). Study design: This is a prospective randomized control study. Sample size: Sample size considerations were based on the survival end ...


A clinical trial seeking patients for a research study for the treatment of Cellular aspects of, Cytology, gastrointestinal endoscopy, Gastric Cancer, Cytological Techniques, Esophageal Cancer, Esophagogastroduodenoscopy

Esophageal cancer is a common malignancy with a very poor prognosis. The principal reason for its poor prognosis is that most tumors are asymptomatic and go undetected until they have spread beyond the esophageal wall and are unresectable. Significant reduction in esophageal cancer mortality will require successful strategies to diagnose ...

Phase N/A

Patients are needed to participate in a clinical research study of Gastric Cancer, Gastroesophageal Junction Adenocarcinoma to evaluate Paclitaxel

The study will compare the efficacy and safety of treatment with pembrolizumab (MK-3475) versus paclitaxel in Asian, programmed death-ligand 1 (PD-L1) positive participants with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma who have progressed after failure of any combination chemotherapy containing a platinum and a fluoropyrimidine agent. The primary study ...


A clinical trial sponsored by Merck Sharp & Dohme Corp. for a research study of Capecitabine, Leucovorin, Cisplatin, 5-fluorouracil, Placebo, Oxaliplatin, Docetaxel

The purpose of this study is to evaluate the efficacy of pembrolizumab (MK-3745) in the neoadjuvant (prior to surgery) or adjuvant (after surgery) treatment of previously untreated adults with gastric and gastroesophageal junction (GEJ) adenocarcinoma. The primary hypotheses of this study are that pembrolizumab plus chemotherapy is superior to placebo ...


A clinical trial seeking patients for a research study of Minnelide™Capsules

A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of MinnelideCapsules given daily for 21 days followed by 7 days off schedule in patients with Advanced Solid Tumors


A Phase 2 clinical study for patients with Gastric Cancer

After curative resection, patients with stage IIIB-IV (M0) gastric cancer were given chemotherapy as follows: S-1 orally at 80 mg/m2 divided in two daily doses for 14 days and oxaliplatin at 130 mg/m2 intravenously over 2 h every 21 days as one cycle. S1 was administered for 16 cycles (12 ...


Patients are needed to participate in a clinical research study to evaluate Helicobacter Pylori Infection, Gastric Cancer, Duodenal Ulcer, Gastric ulcer

Helicobacter pylori (H.pylori) is a major human pathogenic bacterium in gastric mucosa which is linked to the development of gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma and gastric cancer. However the regulatory mechanism of H.pylori-induced immune response is not clear. Long non-coding RNA (lncRNA) has recently emerged as key ...

Phase N/A

A clinical trial to evaluate treatments for patients with Gastric Cancer, Gastro Esophageal Junction Cancer

In this single-centre, open-label, monocenter study, the investigators will enroll 20 patients with resectable cancer of the stomach of GEJunction. All patients will be treated with 1 cycle of atezolizumab monotherapy, followed by 4 cycles of combinationtherapy of atezolizumab, capecitabine, oxaliplatin and docetaxel, followed by surgery.